We recently demonstrated that osteocalcin, a marker of bone remodeling, is higher in women with gestational diabetes (GDM) compared to women with normal glucose tolerance during pregnancy [CON] and related to enhanced insulin secretion in these women [2]. This evidence concerns the gene INS and gestational diabetes.